Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI 882370 |
Trade Name | |
Synonyms | XP-102|BI-882370|BI882370|XP 102|XP102 |
Drug Descriptions |
BI 882370 is a Raf kinase inhibitor with potent activity against the inactive conformation of Braf and may result in tumor regression (PMID: 26916115). |
DrugClasses | BRAF Inhibitor 25 RAF Inhibitor (Pan) 28 |
CAS Registry Number | 1392429-79-6 |
NCIT ID | C187123 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Afatinib + BI 882370 | Afatinib BI 882370 | 1 | 0 |
BI 882370 | BI 882370 | 0 | 1 |
BI 882370 + Cetuximab | BI 882370 Cetuximab | 1 | 0 |
BI 882370 + Trametinib | BI 882370 Trametinib | 2 | 1 |